Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate
Overview
What is Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
A single-entity amphetamine product combining the neutral sulfate salts of dextroamphetamine and amphetamine, with the dextro isomer of amphetamine saccharate and d, l-amphetamine aspartate monohydrate.
Inactive Ingredients:
Colors:
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets 12.5 mg, 15 mg, 20 mg, and 30 mg contain FD&C Blue No. 1 Aluminum Lake and FD&C Yellow No. 6 Aluminum Lake as color additives.
What does Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate look like?
What are the available doses of Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
Sorry No records found.
What should I talk to my health care provider before I take Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
Sorry No records found
How should I use Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Regardless of indication, amphetamines should be administered at the lowest effective dosage, and dosage should be individually adjusted according to the therapeutic needs and response of the patient. Late evening doses should be avoided because of the resulting insomnia.
What interacts with Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma.
Agitated states.
Known hypersensitivity or idiosyncrasy to amphetamine.
Patients with a history of drug abuse.
In patients known to be hypersensitive to amphetamine, or other components of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products (see ).
Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis (see and ).
What are the warnings of Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
Serious Cardiovascular Events
Array
Array
Stimulant medications cause a modest increase in average blood pressure (about 2 mmHg to 4 mmHg) and average heart rate (about 3 bpm to 6 bpm) (see ), and individuals may have larger increases. While the mean changes alone would not be expected to have short-term consequences, all patients should be monitored for larger changes in heart rate and blood pressure. Caution is indicated in treating patients whose underlying medical conditions might be compromised by increases in blood pressure or heart rate, e.g., those with preexisting hypertension, heart failure, recent myocardial infarction, or ventricular arrhythmia (see ).
Array
Children, adolescents, or adults who are being considered for treatment with stimulant medications should have a careful history (including assessment for a family history of sudden death or ventricular arrhythmia) and physical exam to assess for the presence of cardiac disease, and should receive further cardiac evaluation if findings suggest such disease (e.g., electrocardiogram and echocardiogram). Patients who develop symptoms such as exertional chest pain, unexplained syncope, or other symptoms suggestive of cardiac disease during stimulant treatment should undergo a prompt cardiac evaluation.
Psychiatric Adverse Events
Array
Administration of stimulants may exacerbate symptoms of behavior disturbance and thought disorder in patients with preexisting psychotic disorder.
Array
Particular care should be taken in using stimulants to treat ADHD patients with comorbid bipolar disorder because of concern for possible induction of mixed/manic episode in such patients. Prior to initiating treatment with a stimulant, patients with comorbid depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression.
Array
Treatment emergent psychotic or manic symptoms, e.g., hallucinations, delusional thinking, or mania in children and adolescents without prior history of psychotic illness or mania can be caused by stimulants at usual doses. If such symptoms occur, consideration should be given to a possible causal role of the stimulant, and discontinuation of treatment may be appropriate. In a pooled analysis of multiple short-term, placebo-controlled studies, such symptoms occurred in about 0.1% (4 patients with events out of 3,482 exposed to methylphenidate or amphetamine for several weeks at usual doses) of stimulant-treated patients compared to zero in placebo-treated patients.
Array
Aggressive behavior or hostility is often observed in children and adolescents with ADHD, and has been reported in clinical trials and the postmarketing experience of some medications indicated for the treatment of ADHD. Although there is no systematic evidence that stimulants cause aggressive behavior or hostility, patients beginning treatment for ADHD should be monitored for the appearance of or worsening of aggressive behavior or hostility.
Long-Term Suppression of Growth
Careful follow-up of weight and height in children ages 7 to 10 years who were randomized to either methylphenidate or non-medication treatment groups over 14 months, as well as in naturalistic subgroups of newly methylphenidate-treated and non-medication treated children over 36 months (to the ages of 10 to 13 years), suggests that consistently medicated children (i.e., treatment for 7 days per week throughout the year) have a temporary slowing in growth rate (on average, a total of about 2 cm less growth in height and 2.7 kg less growth in weight over 3 years), without evidence of growth rebound during this period of development. Published data are inadequate to determine whether chronic use of amphetamines may cause a similar suppression of growth, however, it is anticipated that they will likely have this effect as well. Therefore, growth should be monitored during treatment with stimulants, and patients who are not growing or gaining weight as expected may need to have their treatment interrupted.
Seizures
There is some clinical evidence that stimulants may lower the convulsive threshold in patients with prior history of seizure, in patients with prior EEG abnormalities in absence of seizures, and very rarely, in patients without a history of seizures and no prior EEG evidence of seizures. In the presence of seizures, the drug should be discontinued.
Peripheral Vasculopathy, Including Raynaud’s Phenomenon
Stimulants, including dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets, used to treat ADHD are associated with peripheral vasculopathy, including Raynaud’s phenomenon. Signs and symptoms are usually intermittent and mild; however, very rare sequelae include digital ulceration and/or soft tissue breakdown. Effects of peripheral vasculopathy, including Raynaud’s phenomenon, were observed in postmarketing reports at different times and at therapeutic doses in all age groups throughout the course of treatment. Signs and symptoms generally improve after reduction in dose or discontinuation of drug. Careful observation for digital changes is necessary during treatment with ADHD stimulants. Further clinical evaluation (e.g., rheumatology referral) may be appropriate for certain patients.
Serotonin Syndrome
Serotonin syndrome, a potentially life-threatening reaction, may occur when amphetamines are used in combination with other drugs that affect the serotonergic neurotransmitter systems such as monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St. John’s Wort (see ). Amphetamines and amphetamine derivatives are known to be metabolized, to some degree, by cytochrome P450 2D6 (CYP2D6) and display minor inhibition of CYP2D6 metabolism (see ). The potential for a pharmacokinetic interaction exists with the coadministration of CYP2D6 inhibitors which may increase the risk with increased exposure to dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets. In these situations, consider an alternative non-serotonergic drug or an alternative drug that does not inhibit CYP2D6 (see ).
Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea).
Concomitant use of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets with MAOI drugs is contraindicated (see ).
Discontinue treatment with dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets and any concomitant serotonergic agents immediately if the above symptoms occur, and initiate supportive symptomatic treatment. If concomitant use of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets with other serotonergic drugs or CYP2D6 inhibitors is clinically warranted, initiate dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets with lower doses, monitor patients for the emergence of serotonin syndrome during drug initiation or titration, and inform patients of the increased risk for serotonin syndrome.
Visual Disturbance
Difficulties with accommodation and blurring of vision have been reported with stimulant treatment.
What are the precautions of Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
General
The least amount of amphetamine feasible should be prescribed or dispensed at one time in order to minimize the possibility of overdosage. Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets should be used with caution in patients who use other sympathomimetic drugs.
Tics
Amphetamines have been reported to exacerbate motor and phonic tics and Tourette’s syndrome. Therefore, clinical evaluation for tics and Tourette’s syndrome in children and their families should precede use of stimulant medications.
Information for Patients
- Array
- Array
- Array
- Array
•
•
•
Instruct patients to call their physician immediately with any signs of unexplained wounds appearing on fingers or toes while taking dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets
•
Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.
Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with amphetamine or dextroamphetamine and should counsel them in its appropriate use. A patient Medication Guide is available for dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets.
The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents. Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have. The complete text of the Medication Guide is reprinted at the end of this document.
Circulation Problems in Fingers and Toes [Peripheral Vasculopathy, Including Raynaud’s Phenomenon]
Drug Interactions
Array
Lower blood levels and efficacy of amphetamines. Increase dose based on clinical response. Examples of acidifying agents include gastrointestinal acidifying agents (e.g., guanethidine, reserpine, glutamic acid hydrochloride, ascorbic acid) and urinary acidifying agents (e.g., ammonium chloride, sodium acid phosphate, methenamine salts).
Array
Adrenergic blockers are inhibited by amphetamines.
Array
Increase blood levels and potentiate the action of amphetamine. Coadministration of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets and gastrointestinal alkalinizing agents should be avoided. Examples of alkalinizing agents include gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) and urinary alkalinizing agents (e.g. acetazolamide, some thiazides).
Array
May enhance the activity of tricyclic or sympathomimetic agents causing striking and sustained increases in the concentration of d-amphetamine in the brain; cardiovascular effects can be potentiated. Monitor frequently and adjust or use alternative therapy based on clinical response. Examples of tricyclic antidepressants include desipramine, protriptyline.
Array
The concomitant use of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets and CYP2D6 inhibitors may increase the exposure of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets compared to the use of the drug alone and increase the risk of serotonin syndrome. Initiate with lower doses and monitor patients for signs and symptoms of serotonin syndrome particularly during dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets initiation and after a dosage increase. If serotonin syndrome occurs, discontinue dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets and the CYP2D6 inhibitor (see , ). Examples of CYP2D6 Inhibitors include paroxetine and fluoxetine (also serotonergic drugs), quinidine, ritonavir.
Array
The concomitant use of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets and serotonergic drugs increases the risk of serotonin syndrome. Initiate with lower doses and monitor patients for signs and symptoms of serotonin syndrome, particularly during dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets initiation or dosage increase. If serotonin syndrome occurs, discontinue dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets and the concomitant serotonergic drug(s) (see and ). Examples of serotonergic drugs include selective serotonin reuptake inhibitors (SSRI), serotonin norepinephrine reuptake inhibitors (SNRI), triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John’s Wort.
Array
Amphetamines may counteract the sedative effect of antihistamines.
Array
Amphetamines may antagonize the hypotensive effects of antihypertensives.
Array
Chlorpromazine blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of amphetamines, and can be used to treat amphetamine poisoning.
Array
Amphetamines may delay intestinal absorption of ethosuximide.
Array
Haloperidol blocks dopamine receptors, thus inhibiting the central stimulant effects of amphetamines.
Array
The anorectic and stimulatory effects of amphetamines may be inhibited by lithium carbonate.
Array
Amphetamines potentiate the analgesic effect of meperidine.
Array
Urinary excretion of amphetamines is increased, and efficacy is reduced, by acidifying agents used in methenamine therapy.
Array
Amphetamines enhance the adrenergic effect of norepinephrine.
Array
Amphetamines may delay intestinal absorption of phenobarbital; coadministration of phenobarbital may produce a synergistic anticonvulsant action.
Array
Amphetamines may delay intestinal absorption of phenytoin; coadministration of phenytoin may produce a synergistic anticonvulsant action.
Array
In cases of propoxyphene overdosage, amphetamine CNS stimulation is potentiated and fatal convulsions can occur.
Array
Time to maximum concentration (T) of amphetamine is decreased compared to when administered alone. Monitor patients for changes in clinical effect and adjust therapy based on clinical response. An example of a proton pump inhibitor is omeprazole.
Array
Amphetamines inhibit the hypotensive effect of veratrum alkaloids.
Drug/Laboratory Test Interactions
Amphetamines can cause a significant elevation in plasma corticosteroid levels. This increase is greatest in the evening. Amphetamines may interfere with urinary steroid determinations.
Carcinogenesis/Mutagenesis, Impairment of Fertility
No evidence of carcinogenicity was found in studies in which d,l-amphetamine (enantiomer ratio of 1:1) was administered to mice and rats in the diet for 2 years at doses of up to 30 mg/kg/day in male mice, 19 mg/kg/day in female mice, and 5 mg/kg/day in male and female rats. These doses are approximately 2.4, 1.5, and 0.8 times, respectively, the maximum recommended human dose of 30 mg/day [child] on a mg/m body surface area basis.
Amphetamine, in the enantiomer ratio present in dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets (immediate-release) (d- to l- ratio of 3:1), was not clastogenic in the mouse bone marrow micronucleus test and was negative when tested in the E. coli component of the Ames test . d, l-Amphetamine (1:1 enantiomer ratio) has been reported to produce a positive response in the mouse bone marrow micronucleus test, an equivocal response in the Ames test, and negative responses in the sister chromatid exchange and chromosomal aberration assays.
Amphetamine, in the enantiomer ratio present in dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets (immediate-release) (d- to l- ratio of 3:1), did not adversely affect fertility or early embryonic development in the rat at doses of up to 20 mg/kg/day (approximately 5 times the maximum recommended human dose of 30 mg/day on a mg/m2 body surface area basis).
Pregnancy
Array
Array
Infants born to mothers dependent on amphetamines have an increased risk of premature delivery and low birth weight. Also, these infants may experience symptoms of withdrawal as demonstrated by dysphoria, including agitation, and significant lassitude.
Usage in Nursing Mothers
Amphetamines are excreted in human milk. Mothers taking amphetamines should be advised to refrain from nursing.
Pediatric Use
Long-term effects of amphetamines in children have not been well established. Amphetamines are not recommended for use in children under 3 years of age with Attention Deficit Hyperactivity Disorder described under INDICATIONS AND USAGE.
Geriatric Use
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets have not been studied in the geriatric population.
What are the side effects of Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
Cardiovascular:
Central Nervous System:
Eye Disorders:
Gastrointestinal:
Allergic:
Endocrine:
Skin:
Musculoskeletal:
What should I look out for while using Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma.
Agitated states.
Known hypersensitivity or idiosyncrasy to amphetamine.
Patients with a history of drug abuse.
In patients known to be hypersensitive to amphetamine, or other components of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products (see ).
Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis (see and ).
What might happen if I take too much Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
Manifestations of amphetamine overdose include restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, panic states, hyperpyrexia and rhabdomyolysis. Fatigue and depression usually follow the central nervous system stimulation. Serotonin syndrome has also been reported. Cardiovascular effects include arrhythmias, hypertension or hypotension and circulatory collapse. Gastrointestinal symptoms include nausea, vomiting, diarrhea and abdominal cramps. Fatal poisoning is usually preceded by convulsions and coma.
How should I store and handle Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate?
Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Keep tightly closed (protect from moisture). Protect from light. Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, USP and amphetamine sulfate, USP. The 5 mg tablets contain 1.25 mg of dextroamphetamine saccharate, 1.25 mg of amphetamine aspartate monohydrate (equivalent to 1.17 mg of amphetamine aspartate anhydrous), 1.25 mg of dextroamphetamine sulfate, USP and 1.25 mg of amphetamine sulfate, USP. The 5 mg tablets are light blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side. They are available as follows:NDC 0378-4541-01bottles of 100 tabletsThe 7.5 mg tablets contain 1.875 mg of dextroamphetamine saccharate, 1.875 mg of amphetamine aspartate monohydrate (equivalent to 1.755 mg of amphetamine aspartate anhydrous), 1.875 mg of dextroamphetamine sulfate, USP and 1.875 mg of amphetamine sulfate, USP. The 7.5 mg tablets are blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4542-01bottles of 100 tabletsThe 10 mg tablets contain 2.5 mg of dextroamphetamine saccharate, 2.5 mg of amphetamine aspartate monohydrate (equivalent to 2.34 mg of amphetamine aspartate anhydrous), 2.5 mg of dextroamphetamine sulfate, USP and 2.5 mg of amphetamine sulfate, USP. The 10 mg tablets are dark blue, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4543-01bottles of 100 tabletsThe 12.5 mg tablets contain 3.125 mg of dextroamphetamine saccharate, 3.125 mg of amphetamine aspartate monohydrate (equivalent to 2.925 mg of amphetamine aspartate anhydrous), 3.125 mg of dextroamphetamine sulfate, USP and 3.125 mg of amphetamine sulfate, USP. The 12.5 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4544-01bottles of 100 tabletsThe 15 mg tablets contain 3.75 mg of dextroamphetamine saccharate, 3.75 mg of amphetamine aspartate monohydrate (equivalent to 3.51 mg of amphetamine aspartate anhydrous), 3.75 mg of dextroamphetamine sulfate, USP and 3.75 mg of amphetamine sulfate, USP. The 15 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4545-01bottles of 100 tabletsThe 20 mg tablets contain 5 mg of dextroamphetamine saccharate, 5 mg of amphetamine aspartate monohydrate (equivalent to 4.6 mg of amphetamine aspartate anhydrous), 5 mg of dextroamphetamine sulfate, USP and 5 mg of amphetamine sulfate, USP. The 20 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4546-01bottles of 100 tabletsThe 30 mg tablets contain 7.5 mg of dextroamphetamine saccharate, 7.5 mg of amphetamine aspartate monohydrate (equivalent to 7.03 mg of amphetamine aspartate anhydrous), 7.5 mg of dextroamphetamine sulfate, USP and 7.5 mg of amphetamine sulfate, USP. The 30 mg tablets are peach, round, tablets debossed with over on one side of the tablet and a quadrisect on the other side.NDC 0378-4547-01bottles of 100 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.PHARMACIST:*
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Amphetamines are thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.
Non-Clinical Toxicology
Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma.Agitated states.
Known hypersensitivity or idiosyncrasy to amphetamine.
Patients with a history of drug abuse.
In patients known to be hypersensitive to amphetamine, or other components of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products (see ).
Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis (see and ).
The least amount of amphetamine feasible should be prescribed or dispensed at one time in order to minimize the possibility of overdosage. Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets should be used with caution in patients who use other sympathomimetic drugs.
Cardiovascular:
Central Nervous System:
Eye Disorders:
Gastrointestinal:
Allergic:
Endocrine:
Skin:
Musculoskeletal:
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Read user comments about the side effects, benefits, and effectiveness of losartan oral.
Overall User Ratings
518Total User Reviews
User Reviews
Learn about
User Reviews
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).